Results 221 to 230 of about 22,658,854 (391)

Designing the Next Generation of Biomaterials through Nanoengineering

Advanced Materials, EarlyView.
Nanoengineering enables precise control over biomaterial interactions with living systems by tuning surface energy, defects, porosity, and crystallinity. This review highlights how these nanoscale design parameters drive advances in regenerative medicine, drug delivery, bioprinting, biosensing, and bioimaging, while outlining key translational ...
Ryan Davis Jr., Ishaan Duggal, Nicholas A. Peppas, Akhilesh K. Gaharwar   +3 more
wiley   +1 more source

Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

Science Translational Medicine, 2013
K. Matsuoka, J. Koreth, Haesook T. Kim, Gregory Bascug, Sean M McDonough, Y. Kawano, K. Murase, C. Cutler, V. Ho, E. Alyea, P. Armand, B. Blazar, J. Antin, R. Soiffer, J. Ritz   +14 more
semanticscholar   +1 more source

Decreased gene expression of interleukin 2 receptor subunit γ (CD132) in tissues of patients with Crohn's disease. [PDF]

World J Gastroenterol
Andreu-Ballester JC, Hurtado-Marcos C, García-Ballesteros C, Pérez-Griera J, Izquierdo F, Ollero D, Jiménez A, Gil-Borrás R, Llombart-Cussac A, López-Chuliá F, Cuéllar C.   +10 more
europepmc   +1 more source

rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. [PDF]

, 1988
Roberto Patarca, Gordon J. Freeman, Joel Schwartz, R. P. Singh, Qui-Tong Kong, Ellen Murphy, Yvonne Anderson, Fengping Sheng, Pratima Singh, Kirk Johnson   +9 more
openalex   +1 more source

Organic AIE Nanoradiosensitizer Potentiates X‐Ray Triggered Continuous Reactive Oxygen Species Generation for Potent Cancer Radioimmunotherapy

Advanced Materials, EarlyView.
Herein, a glutathione‐responsive system (named THN) is prepared for X‐ray‐triggered sustained ROS generation for efficient antitumor immunotherapy. The double‐promoting ROS generation of THN induced massive immunogenic cancer cell death and polarized M2 macrophages into the M1 phenotype for enhanced antitumor immunotherapy.
Qingyong Xu, Minmin Zhang, Qinqin Huang, Song Gao, Sitong Chu, Qi Li, Wanyao Chen, Xinglong Zhang, Tianfu Zhang, Ben Zhong Tang, Shipeng Ning   +10 more
wiley   +1 more source

Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. [PDF]

Cancer Immunol Immunother
Pakola SA, Ojala N, Kudling TV, Clubb JHA, Jirovec E, van der Heijden M, Arias V, Haybout L, Basnet S, Grönberg-Vähä-Koskela S, Quixabeira DCA, Santos JM, Cervera-Carrascon V, Hemminki O, Kanerva A, Mustonen H, Puolakkainen P, Seppänen H, Hemminki A.   +18 more
europepmc   +1 more source

Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2.

, 1988
E M Saltzman, R R Thom, J E Casnellie
openalex   +1 more source

Universal Method for Covalent Attachment of Hydrogels to Diverse Polymeric Surfaces for Biomedical Applications

Advanced Materials, EarlyView.
A universal, reagent‐free strategy is presented for covalently attaching hydrogels to diverse polymeric substrates through reactive oxygen species. The scalable, linker‐free approach enables robust adhesion and broad material compatibility, advancing the fabrication of hybrid solid–hydrogel systems for next‐generation biomedical devices and bioprinting
Masoud Zhianmanesh, Azin Khodaei, Matthew Crago, Oliver Lotz, Sina Naficy, Fariba Dehghani, Marcela Bilek, Saber Amin Yavari, Behnam Akhavan   +8 more
wiley   +1 more source

Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2. [PDF]

Ther Adv Med Oncol
Reitmajer M, Nanz L, Müller N, Leiter U, Amaral T, Aebischer V, Flatz L, Forschner A.   +7 more
europepmc   +1 more source

Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. [PDF]

, 1986
John W. Lowenthal, J C Cerottini, H. Robson MacDonald   +2 more
openalex   +1 more source